Abiraterone Acetate

Drug

Related News

FDA Approves Three New Targeted Therapies for Advanced Prostate Cancer

Jun 16, 2026

The FDA has approved three new targeted therapies for different stages of advanced prostate cancer: Truqap for PTEN-deficient tumors, rucaparib for BRCA-mutated castration-resistant disease, and Akeega for BRCA2-mutated castration-sensitive cancer.

STAMPEDE Analysis Links Low On-Treatment PSA to Better Survival in Advanced Prostate Cancer

May 13, 2026

A post hoc STAMPEDE analysis found lower on-treatment PSA levels were strongly associated with improved long-term survival in advanced prostate cancer, but disease burden still affected outcomes.